The same treatments reduced TNFα expression under pre-menopausal (PEDF: p = 0.001; JSH-23: p = 0.7668; PEDF/JSH-23: p = 0.7593) and post-menopausal (PEDF: p = 0.2986; JSH-23: p= 0.0006; PEDF/JSH-23: p < 0.0001) conditions in MDA-MB-231 (Figure 3Y–AF,c). The gene discussed is SERPINF1; the disease is atrial fibrillation.